Peak flow variability in childhood and body mass index in adult life
To the Editor:
Several cross-sectional studies have shown an association between obesity and asthma, and meta-analyses of prospective studies have concluded that obesity precedes the development of asthma and wheezing in both adults and children. 1 However, a recent study of 2 longitudinal cohorts suggested that children with asthma are at increased risk of subsequent development of obesity. 2 The nature and the direction of the association between the 2 conditions thus remain unclear. 3 Diurnal peak flow variability (PFvar) is considered an important measurement of airway lability in the screening and diagnosis of asthma in population-based studies. We have previously found increased PFvar and response to albuterol in girls who became overweight or obese during the school years as compared with those who did not, 4 suggesting a link between an abnormal regulation of the airway tone and weight gain in the school years. The aim of the current study was to determine whether airway lability in children is associated with subsequent body mass index (BMI) increase up to young adult life in the longitudinal Tucson Children's Respiratory Study birth cohort. 5 Detailed methods and definitions are reported in this article's Online Repository at www.jacionline.org. Questionnaires on participants' respiratory symptoms and physical activity were completed by their parents at age 11 years (Yr11: mean 6 SD, 10.7 6 0.5 years) and 16 years (Yr16: 16.6 6 0.6 years) and by participants themselves at age 22 years (Yr22: 22.1 6 0.9 years) and 26 years (Yr26: 26.5 6 0.9 years). At each survey, skin prick tests were performed and BMI (kg/m 2 ) was calculated. At a mean age of 10.8 years, peak expiratory flow data were collected for 1 week and PFvar was calculated as previously reported 6 (see this article's Online Repository at www.jacionline.org). BMI and PFvar values were logarithmically transformed (base 10) to obtain a normal distribution. The potential confounding effects of parental education, ethnicity, metabolic equivalents of task, and smoke exposure were also tested. This study was approved by the Human Subjects Committee at the University of Arizona, and informed consent was obtained from the parents before age 18 years and, subsequently, from the participants themselves.
Among the 600 children with PFvar information at Yr11, the number of subjects with subsequent BMI information was 500 at Yr16, 485 at Yr22, and 453 at Yr26 (see this article's Online Repository at www.jacionline.org). The characteristics of study subjects at Yr11 in comparison with those who were excluded because of missing information on BMI or PFvar (see Table E1 in this article's Online Repository at www.jacionline.org) and at each subsequent survey (see Table E2 in this article's Online Repository at www.jacionline.org) are reported in this article's Online Repository at www.jacionline.org. At Yr11, the geometric mean (95% CI) PFvar was 7.6% (7.3-8.0) , range 0.7% to 41.9%, and 62 children (10.3%) had a high PFvar. In univariate analyses, In random-effects multivariate models with log-transformed BMI as the continuous dependent variable, we found subjects with high PFvar to have only marginally increased BMI at Yr11 but significantly higher BMI at all other ages compared with subjects with normal PFvar, with the largest differences achieved by Yr26 (Fig E2) . The best-fitting model (see Table E3 in this article's Online Repository at www.jacionline.org) included both age and age-squared terms, consistent with deceleration of BMI increase from childhood to young adult life; also (Table E3) , the effect of high PFvar on subsequent BMI was mainly explained by the interaction between high PFvar and age, indicating that after adjustment for covariates, high PFvar at Yr11 was associated with a steeper increase over time (or, in other words, a higher velocity of growth) in BMI. After further adjustment of the model for BMI at Yr11 and/or smoke exposure, results remained virtually unchanged (data not shown). However, when random-effects models were stratified by sex, we found notable differences in the association between PFvar and BMI increase between females and males (Table I and Fig 1) . The interaction between high PFvar and age was highly significant in females (P < .001) but not in males (P 5 .968) , showing that the effect of high PFvar on the subsequent BMI increase was present only in the former group (Table I) . These effects were confirmed when repeating the analysis in subjects who were neither overweight/obese nor had asthma at Yr11 (see this article's Online Repository at www.jacionline.org).
In summary, we found high PFvar at Yr11 to predict a steeper subsequent BMI increase up to young adult life independent of multiple covariates, including current asthma at Yr11. Interestingly, the effects of high PFvar at Yr11 were much stronger on subsequent than on concomitant levels of BMI, suggesting that our findings are very unlikely to be explained by concomitant effects of obesity on airway lability. In other words, if the relationship between PFvar and BMI were simply explained by the fact that subjects with a higher BMI are deconditioned and have a lower lung function, one might expect a better correlation between high PFvar and elevated BMI during childhood surveys, which was not the case in our study. These findings support the possibility that the association between asthma and obesity may be bidirectional or due to shared factors that preexist both conditions 3 (for previous literature and the limitations of the study, see this article's Online Repository at www.jacionline. org). Obesity and asthma are known to share common genetic mechanisms 7, 8 ; furthermore, developmental and early-life factors have been suggested as affecting the development of both obesity and asthma. 8, 9 We propose that such common factors might cause both an alteration in the regulation of airway tone and a greater tendency to gain weight during the growing years and that the asthma-related phenotype might thus precede the obesity phenotype.
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Enrico Lombardi, MD Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy
To the Editor: Emerging data from a phase 2 multicenter study confirm the utility of allergen-specific immunotherapy (AIT) with natural proteins to induce desensitization and tolerance to peanut. 1 Alternatively, hypoallergenic variants of major peanut allergens have been designed to increase the safety of AIT by reducing IgE-mediated side effects. [2] [3] [4] [5] Hypoallergens have a reduced capacity to bind IgE while retaining their T-cell stimulatory ability and could be administrated at higher doses and consequently increase the safety and efficacy of AIT. Two basic approaches to produce hypoallergens for peanut AIT have been reported: the chemical modification of the major peanut allergens Ara h 2 and 6 2, 3 and the modification of Ara h 1-3 by site-directed mutagenesis. 4, 5 This study reports a novel concept for genetic engineering of hypoallergenic variants of Ara h 2 and Ara h 6, the 2 most frequently recognized and most potent peanut allergens. We generated modified variants of these allergens with preserved T-cell stimulatory capacities and reduced IgE binding to maintain the desensitizing potential. Hypoallergenic variants were designed on the basis of in silico analyses of the known 3-dimensional structures and amino acid sequences of Ara h 2 (PBD: 3OB4) and Ara h 6 (PBD: 1W2Q) and taking into account linear IgE 4, 6 and T-cell epitopes 7 (Fig 1, A; see Fig E1 in this article's Online Repository at www.jacionline.org). For detailed material and methods, see this article's Methods section in the Online Repository at www.jacionline.org. Our analyses revealed that most of the known linear IgE epitopes were located in the unstructured loops of Ara h 2, whereas T-cell epitopes were mostly identified in the a-helical core. Thus, the loops that form major parts of the antibody-accessible surface of these proteins were modified by changing the order of neighboring segments of the protein sequences. In each loop, the sequence was divided into short stretches of 5 to 10 amino acid residues. This caused modifications of sequential and conformational IgE epitopes. In contrast, cysteines involved in the formation of disulfide bonds, a-helices, and short turns were left unchanged to preserve the protein core, which is essential for protein stability and contains most of the known T-cell epitopes. 7 The modified and the wild-type allergens were expressed as soluble proteins in Escherichia coli with structures typical for proteins dominated by a-helices (see Fig E2 in this article's Online Repository at www.jacionline.org).
Sera from 34 well-characterized individuals with peanut allergy sensitized to Ara h 2 and Ara h 6 (see Table E1 in this article's Online Repository at www.jacionline.org) were analyzed for IgE binding to the mutated variants by IgE ELISA (Fig 1, B; see Fig E3 and Table E2 in this article's Online Repository at www.jacionline.org). Mutated molecules showed significantly less IgE-binding capacities than did rAra h 2 wt (55% 6 22% SD reduction; P <.001), rAra h 6 wt (39% 6 23% SD reduction; P < .001), and purified nAra h 2 (61% 6 18% SD reduction; P < .001) and nAra h 6 (62% 6 19% SD reduction; P < .001). For more than 60% of the sera, IgE binding to the mutated allergens was reduced by 50% to 94% as compared with their natural counterparts. However, some patient's sera retained a high level of IgE reactivity to the modified allergens (IgE-binding reduction <50% ; Fig 1, B ; Table E2 ). The reduction in IgE binding was not associated with allergen-specific IgE levels (P 5 .8061 for Ara h 2; P 5 .2672 for Ara h 6). In addition, immunoblotting demonstrated a strong specific IgE reactivity to the purified natural and recombinant wild-type allergens, whereas IgE binding to the mutated proteins dropped by more than 50% (Fig E2, A and B) . Notably, the IgE binding of the hypoallergens was also significantly reduced compared with the recombinant wild-type allergens, which clearly illustrated the effects of the introduced modifications. In line with reduced IgE binding, the modified variants of Ara h 2 and Ara h 6 displayed reduced basophil activation, suggesting their markedly reduced allergenic potency (Fig 1, C; see Fig E4 in this article's Online Repository at www.jacionline.org). This was reflected by significantly lower percentages of activated basophils at Ara h 2 concentrations ranging from 1 pg/mL to 1 ng/mL (P <.01), illustrating an average reduction of 3 logs. A similar trend, a 5-to 10-fold reduction, was observed for Ara h 6 mut using basophils from 3 donors with peanut allergy (Fig 1, C; Fig E4) . This reduction in IgE binding and effector cell activation, achieved as a result of the modification of unstructured regions, was similar or higher to the ones achieved for Ara h 2 and Ara h 6 linearized
METHODS
The Tucson Children's Respiratory Study (CRS) is a longitudinal cohort study involving 1246 children enrolled at birth between May 1980 and October 1984.
E1 Questionnaires on participants' respiratory symptoms were completed by their parents at Yr11 (mean 6 SD, 10.7 6 0.5 years) and Yr16 (mean 6 SD, 16.6 6 0.6 years) and by participants themselves at Yr22 (mean 6 SD, 22.1 6 0.9 years) and Yr26 (mean 6 SD, 26.5 6 0.9 years). At each survey, current asthma was defined as a positive report of asthma diagnosed by a physician, with at least 1 asthma attack or wheezing episode during the previous year. Information on sport-related physical activity during the previous year was also collected at each survey using the questions: ''Is this child a member of a sports team?'' at Yr11; ''Does this child participate in sports?'' at Yr16; and ''During the past year, have you exercised regularly?'' at Yr22 and Yr26. Metabolic equivalents of task (METs) were calculated according to Ainsworth et al E2 using the questions ''If yes, in which sports? (hours per week)'' at Yr11 and Yr16 and ''Which type of exercise have you done regularly? (hours per week)'' at Yr22 and Yr26. METs were categorized into 3 levels, namely, 1, ''0 MET hours per week''; 2, ''1 to 40 MET hours per week''; and 3, ''more than 40 MET hours per week.'' Skin prick tests were performed at each survey. For the sake of consistency, in this study we considered only the 6 aeroallergens that were tested in all 4 surveys: Bermuda grass, careless weed, olive, mesquite, mulberry, and Alternaria alternata (Hollister-Stier Laboratories, Everett, Washington, DC). Histamine and a negative control consisting of 50% glycerin were also applied. Tests were read at 20 minutes, and the size of the wheal elicited by each allergen was recorded as the longest diameter plus the perpendicular diameter (in mm). Wheal sizes of 3 mm or greater, after subtracting the negative control, were considered positive. A subject was considered atopic if he or she had a positive skin test reaction to at least 1 aeroallergen.
Study nurses used beam balance scales at each survey to measure weight (Health-o-meter; Continental Scale Corp, Chicago, Ill). Height was measured with the subject barefoot and erect against a vertical backboard or wall-mounted scale (Accustat-Stadiometer; Genentech, San Francisco, Calif). Self-reported weight and height were also available from the questionnaires. BMI was calculated as weight (kg)/square of height (m 2 ). Subjects were considered to be ''obese'' if their BMI was greater than or equal to 95th percentile of Centers for Disease Control and Prevention's 2000 US sexand age-standardized values up to the age of 17 years E3 or if their BMI was greater than or equal to 30 kg/m 2 over age 17 years. E4 Subjects were considered to be ''overweight/obese'' if their BMI was greater than or equal to 85th percentile of Centers for Disease Control and Prevention's 2000 US sex-and age-standardized values up to the age of 17 years E3 or if their BMI was greater than or equal to 25 kg/m 2 over age 17 years.
E4
At a mean age of 10.8 years, subjects were trained by study nurses on the use of a home peak expiratory flow (PEF) meter (''Mini-Wright''; Clements Clarke International, Harlow, Essex, United Kingdom) and parents were asked to record on a diary the best of 3 attempts of their children in the morning, in the afternoon, and before going to bed at night. PEF data were collected for 1 week. To avoid the ''learning effect'' on PEF measurements, as previously reported, E5 measures from the first morning of the PEF recording period were eliminated from the analysis. Only those subjects who recorded PEF measurements at least twice a day for 4 days or more (after exclusion of the first morning of the recording period) were included in the analysis.
E5,E6
The amplitude percent mean E5,E7 was chosen as the PFvar index and defined as follows:
PFvar5
+ðmaximum daily PEF2minimum daily PEFÞ=mean daily PEF Number of days in the period 3100
Consistent with our previous report, high PFvar at Yr11 was defined as a PFvar value greater than or equal to 16.6% (ie, above the 90th percentile of a healthy reference subgroup of subjects whose skin test results were negative, who had never wheezed, nor had been diagnosed as having asthma).
E5
The potential confounding effects of parental education, ethnicity, and smoke exposure were also tested. Maternal and paternal education was assessed at child's enrollment in the CRS and categorized into ''12 years or more'' and ''12 years or less.'' Ethnicity was categorized on the basis of ethnicity of parents (''both parents non-Hispanic white,'' ''at least 1 Hispanic white parent,'' or ''other''). For smoke exposure, 4 combination groups were generated on the basis of parental smoking at child's birth and active participant smoking between Yr16 and Yr26, as previously reported This study was approved by the Human Subjects Committee at the University of Arizona, and informed consent was obtained from the parents before age 18 years and, subsequently, from the participants themselves.
Statistical analysis
BMI and PFvar values were logarithmically transformed (base 10) to obtain a normal distribution. Student t test and the chi-square test were used for comparisons of means and proportions, respectively. Linear regression was used in the univariate analysis to assess the relation between PFvar at Yr11 and BMI at Yr11, Yr16, Yr22, and Yr26, respectively. To adjust for the intrasubject serial correlation of repeated observations, generalized estimating equations were used to assess the association between dichotomous PFvar at Yr11 and the categorical variable indicating obese subjects at each of the 4 surveys, E9 and random-effects models were used for all the multivariate longitudinal analyses with log-transformed BMI as the continuous dependent variable. E9 In the random-effects models, age was centered to the youngest child included at Yr11. Linear contrast was used to estimate survey-specific effects. Stata version 14.0 was used for analysis. Potential confounders of the relationship between PFvar and BMI were included in the models a priori. Statistical significance was tested at a 2-sided alpha level of 0.05.
RESULTS
PEF variability information at Yr11 was collected for 600 children, and all children had 1 or more BMI measurements. BMI was assessed by the study nurses at Yr11 (n 5 599), Yr16 (n 5 448), Yr22 (n 5 397), and Yr26 (n 5 336). Excellent correlation was found between BMI assessed by the study nurses and questionnaire-reported BMI (Spearman rho, 0.97 at Yr11, 0.96 at Yr16, 0.98 at Yr22, and 0.95 at Yr26). For this reason, to minimize the potential selection bias due to missing information at follow-up, questionnaire-reported BMI at Yr16, Yr22, and Yr26 was used for those subjects for whom BMI assessed by the study nurses was missing at those surveys. Thus, among the 600 children with PFvar information at Yr11, the final number of subjects with subsequent BMI information was 500 at Yr16, 485 at Yr22, and 453 at Yr26.
The characteristics of the study subjects at each survey are reported in Table I . At Yr11, as compared with participants who were included in the present study, those who were excluded because they had missing information on BMI or PFvar were slightly older, more physically active, and had a higher proportion of non-Hispanic white parents (Table E1 ). In contrast, no significant differences were found in sex, asthma, atopy, and parental education.
Geometric mean (95% CI) BMI values at each survey for the subjects included in the study are also reported in Table I . The proportion of overweight/obese subjects was 27.4% at Yr11, 23.2% at Yr16, 39.2% at Yr22, and 50.8% at Yr26. At Yr11, the geometric mean (95% CI) PFvar was 7.6% (7.3-8.0 ), range 0.7% to 41.9%, and 62 children (10.3%) had a high PFvar.
In univariate analyses, a significant linear correlation was found between log-transformed PFvar at Yr11 and log-transformed BMI at Yr11 (r 5 0.10; P 5 .015), Yr16 (r 5 0.14; P 5 .001), Yr22 (r 5 0.14; P 5 .002), and Yr26 (r 5 0.11; P 5 .019). In addition, as compared with subjects with normal PFvar, those with high PFvar had higher BMI at Yr11 (P 5 .037), Yr16 (P 5 .0001), Yr22 (P 5 .0003), and Yr26 (P 5 .068). PFvar at Yr11 tended to have a stronger association with subsequent (Yr16, Yr22, and Yr26) than with concomitant (Yr11) BMI. Consistent with this scenario, Fig E1  shows In random-effects models that used log-transformed BMI at Yr11, Yr16, Yr22, and Yr26 as the dependent variable, after adjusting for sex, maternal and paternal education, and ethnicity as fixed covariates and for age, age squared, concurrent asthma, atopy, and METs at each survey as time-dependent covariates, we found subjects with high PFvar to have only marginally increased BMI at Yr11 but significantly higher BMI at all other ages than subjects with normal PFvar, with the largest differences achieved by Yr26 (Fig E2) . Likelihood ratio tests indicated that the best-fitting model (Table E3) included both age and agesquared terms, consistent with the previously described deceleration in BMI increase from childhood to young adult life. The best-fitting model also included an interaction term between high PFvar and age (P < .01), indicating that after adjustment for covariates, high PFvar at Yr11 was strongly associated with a steeper increase in BMI over time. An additional interaction term between high PFvar and age squared was also tested, found nonsignificant, and therefore removed from the final model. After further adjustment of the model for smoke exposure, results remained virtually unchanged (data not shown). Similarly, results did not change when the analysis was repeated using only BMI values from direct measurements by the study nurses.
Of note, when random-effects models were stratified by sex, we found notable differences in the association between PFvar and BMI increase between females and males (Table I and Fig 1) . The interaction between high PFvar and age was highly significant in females (P < .001) but not in males (P 5 .968) , showing that the effect of high PFvar on the subsequent BMI increase was present only in the former group. Indeed, among males no association was seen between high PFvar and BMI levels at any age. These results were confirmed after restricting analyses for subjects who did not have current asthma and were not overweight/obese at Yr11 (196 females and 157 males). Once again, the interaction between high PFvar and age was significant in females (P 5 .039), but not in males (P 5 .935 ).
DISCUSSION
In this study, we found high PFvar at Yr11 to predict a steeper subsequent BMI increase up to young adult life independent of multiple covariates, including parental education, level of physical activity, and current asthma at Yr11. By Yr26, participants who had high PFvar in childhood were nearly twice as likely to be obese as were their peers who had normal PFvar in childhood. Interestingly, the effects of high PFvar were much stronger on subsequent than on concomitant levels of BMI, suggesting that our findings are very unlikely to be explained by concomitant effects of obesity on airway lability.
The prevalence rates of obesity and asthma have increased dramatically in many countries in recent decades, E10 and several cross-sectional studies have shown an association between these conditions, both in children E11,E12 and in adults. E13,E14 In addition, longitudinal studies have found that excess weight increases the risk of subsequent asthma development in childhood E15-E17 as well as in adult life. E18-E20 Meta-analyses have confirmed these longitudinal relations. In children, the combined results from 6 prospective studies showed that the combined RR of obesity for subsequent physician-diagnosed incident asthma at least 1 year after BMI assessment was significant in both boys (RR 5 1.40; 95% CI, 1.01-1.93) and girls (RR 5 1.53; 95% CI, 1.09-2.14). E21 A meta-analysis that combined the results from 9 studies on the effects of high birth weight on subsequent asthma found a pooled RR of 1.2 (95% CI, 1.1-1.3) in a total of 110,402 children.
E22 In adults, a meta-analysis of 7 longitudinal studies including a total of 333,102 subjects found that a BMI value of greater than or equal to 25 kg/m 2 conferred an odds ratio of 1.51 (95% CI, 1.27-1.80) for incident asthma when compared with normal weight, and this effect showed a dose-response relationship. E23 Several mechanisms have been proposed to explain the link between obesity and asthma. E24 Mechanical factors, such as reduced functional residual capacity and low tidal volume with subsequent increase in airway smooth muscle stiffness and bronchial hyperreactivity, have been shown to play a possible role. E24,E25 The increase in proinflammatory adipokines, such as leptin, eotaxin, IL-6, and TNF-a, and the decrease in adiponectin and its anti-inflammatory effects have been reported to underlie the state of chronic systemic inflammation present in obesity and have been suggested to be also involved in the inflammation present in asthma. E24,E26 Finally, comorbid conditions, such as dyslipidemia, gastroesophageal reflux, type 2 diabetes, or sleep-disordered breathing, may also play a role in the relationship between obesity and asthma.
E24
The above-postulated mechanisms are largely based on the assumption that obesity is causally linked to asthma risk. However, a recent follow-up of subjects with asthma during childhood in 2 separate cohorts suggested that the inverse association may also be true: children with asthma are at increased risk of subsequently developing obesity. E27 It is thus possible that the association between asthma and obesity may be bidirectional, with different factors explaining the association between obesity and asthma as compared with those explaining that between asthma and obesity. Alternatively, a more parsimonious explanation could be that the link between these conditions is due to shared factors that preexist both and are expressed as either asthma or obesity at different times during the lifetime as a function of other, unknown determinants. In this framework, obesity and asthma are known to share common genetic mechanisms. E28,E29 In a study on 1001 monozygotic and 383 dizygotic same-sex twin pairs, 8% of the genetic component of obesity was shown to be shared with asthma. E30 In line with this scenario, an approximately 0.45-Mb genomic inversion at 16p11.2 (which includes multiple potential asthma and obesity candidate genes) was recently associated with the risk for the joint occurrence of asthma and obesity in 5 independent studies, supporting the existence of a possible common genetic predisposition to both conditions. E31 Developmental and early-life factors, such as prenatal exposure to specific nutrients and patterns of colonization of the infant gut, have also been suggested as affecting the development of both obesity and asthma. E28,E32 We reasoned that if such common factors do exist, they could cause both an alteration in the regulation of airway tone and a greater tendency to gain weight during the growing years and that the asthma-related phenotype could precede the obesity phenotype even in subjects without asthma. Consistently, in the present study, high PFvar at Yr11 predicted BMI increase and development of obesity by Yr26 independent of asthma diagnosis and other confounders, and these effects were confirmed when repeating the analysis in subjects who were neither obese nor asthmatic at Yr11.
PFvar is considered an important measurement in screening for asthma in population-based studies E33 and is recommended by asthma guidelines as a possible tool for the diagnosis and management of the disease.
E34 However, we have previously shown that PFvar is present in the nonatopic toddlers long after wheezing symptoms have ceased E5 and it may represent an indicator of airway lability only partly related to asthma symptoms. These observations, together with the finding that high PFvar in childhood was associated with a steeper BMI increase by Yr26 independent of asthma and even after restricting analyses to those without asthma, suggest that it is unlikely that respiratory symptoms and the consequent reduction in physical activity may be responsible for the weight gain among subjects with high PFvar. In addition, to reduce potential confounding by physical activity, we included METs (based on sport-related physical activity at the 4 surveys) as an independent variable in longitudinal multivariate analysis and confirmed the relationship between PFvar and subsequent BMI in these models. However, it should be noted that our questionnaires focused on sports participation at Yr11 and Yr16, and on regular exercise activity at Yr22 and Yr26, and were not designed to thoroughly investigate the complex relationship between sedentary lifestyle, obesity, and asthma.
A limitation of this study is the potential selection bias of the participants, because information on PFvar at Yr11 and subsequent BMI was not available for the whole population. However, we found that at Yr11 those who were excluded because of missing information on PEF were slightly older, more physically active, and had a higher proportion of non-Hispanic white parents as compared with participants who were included in the present study, but were not significantly different as long as sex, asthma, atopy, and parental education were concerned.
We also attempted to minimize the potential limitation due to missing BMI information after Yr11. Because excellent correlation was found between BMI assessed by the study nurses and self-reported BMI in the questionnaires, self-reported BMI information at Yr16, Yr22, and Yr26 was used for those subjects for whom BMI assessed by the study nurses was missing at those surveys, thus largely decreasing the number of subjects with missing BMI information.
Other important potential limitations are due to the nature itself of PEF measurements, which are by design effort-dependent, while PEF devices offer no objective assurance as to the effort of the maneuver. However, the effect of these potential limitations would be an increase in the ''background noise'' and a decrease in the detectable effect of PFvar on subsequent BMI. Also, if the relationship between PFvar and BMI were simply explained by the fact that subjects with a higher BMI are deconditioned and have a lower lung function, one might expect a better correlation between high PFvar and elevated BMI at all surveys, which was not the case in our study. Furthermore, to ensure that only PEF measurements with a good adherence were analyzed, only those subjects who recorded PEF measurements at least twice a day for 4 or more days (after exclusion of the first morning of the recording period) were included in the analysis. Another limitation is that PFvar was measured during only 1 week at Yr11 instead of having repeated measurements over the period of the study.
Although our finding that high PFvar preceded BMI gain applies to the entire CRS study population, we found indication that this association is stronger in females than in males, among whom it did not reach statistical significance. The literature is not always consistent in showing differences by sex in the relation of asthma and obesity. E35 Although in adults a stronger association between overweight/obesity and asthma is generally found in females than in males, E29 in children this association has been reported both in females and in males E16,E17,E36,E37 and a meta-analysis of 6 studies found a larger effect of overweight/ obesity on subsequent asthma incidence in boys than in girls.
E38
In our population we have previously shown that females who became overweight or obese between age 6 and 11 years were 7 times more likely to develop subsequent asthma symptoms by age 13 years than females who were not overweight or obese. E15 We have also shown a higher prevalence of abnormal PFvar in girls who became overweight or obese during the school years as compared with those whose BMI level did not change or decreased during the same time interval. E15 These girls were also significantly more likely to show a positive response to albuterol than those who did not become overweight or obese during the same period, thus suggesting the presence of an abnormal regulation of airway tone. The reasons why the link between high PFvar and steeper increase in BMI may be stronger in girls than in boys remain unclear, although hormonal differences are likely to play a role. E35,E39 In conclusion, we found PFvar in childhood to be a significant predictor of subsequent BMI increase by Yr26, particularly in females, suggesting that the relationship between obesity and asthma-related phenotypes may not be unidirectional. Developmental and genetic factors common to asthma and obesity may explain at least in part the association between these 2 phenotypes.
FIG E1.
Proportions of obese children at the 4 surveys by PFvar at age 11 years. P values related to group differences at each time point were tested using linear contrast from longitudinal Generalized estimating equation univariate analyses with PFvar at Yr11 as the independent variable and obesity at Yr11, Yr16, Yr22, and Yr26 as the dependent variable.
FIG E2.
Linear prediction of base 10 log-transformed BMI vs age for subjects with high (red circles) and normal (blue circles) PFvar at Yr11. Linear predictions were calculated from random-effects models adjusted for sex, maternal and paternal education, and ethnicity as fixed effects and current asthma, atopy, and METs at each survey as time-dependent covariates in the whole study group. P values related to group differences at each time point were tested using linear contrast. GM, Geometric mean. *Totals are not the same for all individual characteristics because information is missing for some subjects. P < .001 by t test vs study subjects at same age. à.1 > P > .05 by x 2 test vs study subjects at same age. §P < .05 by x 2 test vs study subjects at same age. GM, Geometric mean. *Totals are not the same for all individual characteristics because information is missing for some subjects.
J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 3 METs were used as an ordinal variable at each survey where the first category was 0 MET h/wk, the second category was between 1 and 40 MET h/wk, and the third category was >40 MET h/wk (see text). àReference category: both non-Hispanic white parents.
